drugset / Trial / NCT01896180
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a pilot, proof of concept study to evaluate the safety and efficacy of ALZ-1101 dosed once daily for 28 days compared to latanoprost 0.005% ophthalmic solution in patients with elevated intraocular pressure not adequately controlled with latanoprost.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALZ-1101 | Unknown | — | Topical |
| Comparator | Latanoprost | Small molecule | 0.005 % | Topical |